Colorectal Cancer (CRC) Withdrawn Phase 1 Trials for Fluorouracil (DB00544)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Withdrawn	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02573220	Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer	Treatment	Camptothecin (DB04690) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT03169777	QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC	Treatment	Avelumab (DB11945) Bevacizumab (DB00112) CD-16 NK-92 cells (DB17465) Capecitabine (DB01101) Cetuximab (DB00002) Cyclophosphamide (DB00531) ETBX-011 (DB17464) ETBX-021 (DB17528) ETBX-051 (DB17529) ETBX-061 (DB17530) Fluorouracil (DB00544) Fulvestrant (DB00947) GI-4000 (DB05698) GI-6207 (DB17532) GI-6301 (DB17533) Leucovorin (DB00650) Nivolumab (DB09035) Nogapendekin alfa (DB18740) Omega-3-acid ethyl esters (DB09539) Oxaliplatin (DB00526) Paclitaxel (DB01229)
NCT00244348	Hepatic Artery Infusion With Oxaliplatin	Treatment	Fluorouracil (DB00544) Oxaliplatin (DB00526)
NCT02785068	Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)